ARTICLE | Company News
Avalon and ImmunoGen antibody deal
January 25, 2001 8:00 AM UTC
IMGN will develop antibody-based cancer therapeutics using gene targets provided by Avalon (Gaithersburg, Md.). IMGN will be responsible for development, manufacturing and marketing of resulting produ...